Boston and Medtronic to fight stent verdict and damages
This article was originally published in Clinica
Executive Summary
Boston Scientific and Medtronic have each been ordered to pay large damages to Johnson & Johnson after the companies were found to have infringed J&J's stent patents. In separate pieces of litigation, Boston was told to pay $324.4 million, while Medtronic's figure is $271.1 million. The two companies are likely to appeal.